Abiopharma

Palleiko Benjamin L 🟡 adjusted position in 10.9K shares (1 derivative) of KalVista Pharmaceuticals, Inc. (KALV) at $13.22 Transaction Date: Aug 21, 2025 | Filing ID: 022965

Audhya Paul K. 🟡 adjusted position in 2.9K shares (1 derivative) of KalVista Pharmaceuticals, Inc. (KALV) at $13.22 Transaction Date: Aug 21, 2025 | Filing ID: 022964

Harford Simon N.R. 🔴 sold 12.5K shares of AMICUS THERAPEUTICS, INC. (FOLD) at $7.60 Transaction Date: Aug 21, 2025 | Filing ID: 000004

Director Duato Joaquin 🟡 adjusted position in 125.8K shares (1 derivative) of JOHNSON & JOHNSON (JNJ) at $179.21 ($48.2M) Transaction Date: Aug 22, 2025 | Filing ID: 000182

Director Fain Eric S 🟢 acquired 5.8K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $2.61 Transaction Date: Aug 25, 2025 | Filing ID: 082638

Director Sherman Darren 🟢 acquired 3.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $2.62 Transaction Date: Aug 25, 2025 | Filing ID: 082636

Director Hochman David P 🟢 acquired 6.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $2.49 Transaction Date: Aug 21, 2025 | Filing ID: 082635

Taylor Andrew Lawrence 🟢 acquired 2.0K shares of Orchestra BioMed Holdings, Inc. (OBIO) at $2.55 Transaction Date: Aug 25, 2025 | Filing ID: 082633

Director Jordan Blair 🔴 sold 200.0K shares of ETHZilla Corp (ETHZ) Transaction Date: Aug 21, 2025 | Filing ID: 080449

ResMed Inc. Daily Stock Update

Director White Dale A. 🟡 adjusted position in 0 shares of Claritev Corp (CTEV) Transaction Date: Aug 21, 2025 | Filing ID: 000147

Chopra Daveen 🔴 sold 2.5K shares of Edwards Lifesciences Corp (EW) at $81.95 Transaction Date: Aug 25, 2025 | Filing ID: 007460

Chung Kevin 🟢 acquired 10.0K shares of SeaStar Medical Holding Corp (ICU) at $0.80 Transaction Date: Aug 22, 2025 | Filing ID: 080440

Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2025 Annual Meeting

CAPR INVESTORS: Kirby McInerney LLP Reminds Capricor Therapeutics, Inc. Investors of Important Deadline and Encourages Investors to Contact the Firm